Neural tube defects in Switzerland from 2001 to 2007: Are periconceptual folic acid recommendations being followed?

Swiss Medical Weekly

Volumn 138, Issue 41-42, 2008, Pages 608-613

  Poretti, Andrea ^a   Anheier, Tanja ^a   Zimmermann, Roland ^b   Boltshauser, Eugen ^a   Aebi, Ch ^c   Antonelli, E ^c   Bar W ^c   Bernet, V ^c   Bianchetti, M ^c   Bittel, M ^c   Blumberg, A ^c   Bucher, H U ^c   Buetti, L ^c   Bussmann, E ^c   Carrel, O ^c   Cattin, P O ^c   Corboz, A ^c   Diebold, P ^c   Dolivo, P ^c   Farron, F ^c   Gehri, M ^c   Giannoni, E ^c   Haenggeli, C A ^c   Hodel, M ^c   Hohlfeld, J ^c   Huppi P ^c   Imahorn, P ^c   Irion, O ^c   Kind, Ch ^c   Kistler, W ^c   Knopfli B ^c   Lapaire, O ^c   Laubscher, B ^c   Leuthardt, R ^c   Lips, U ^c   Malzacher, A ^c   Mayr, J ^c   Mc Dougall, J ^c   Micheli, J L ^c   Monkhoff M ^c   Neuhaus, T J ^c   Pezzoli, V ^c   Reinhard, L ^c   Renevey, F ^c   Roten, H ^c   Rudin, Ch ^c   Schlumbom, V ^c   Schwobel M ^c   Sizonenko, S ^c   Stocker, S ^c   Stussi Ch ^c   Tabin, R ^c   Terrier, P ^c   Wildhaber, B ^c   Wildhaber, J ^c   Wisser, J ^c   Wopmann, M ^c   Zachariou, Z ^c   Zeilinger, G ^c   Zemmouri, A ^c   Zimmermann, U ^c   Zimmermann, H ^c   Beeli, D ^c   more..

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c University Children's Hospital ^*

Author keywords

Anencephaly; Encephalocele; Folic acid supplementation; Myelomeningocele; Neural tube defects

Indexed keywords

FOLIC ACID;

ANENCEPHALUS; ARTICLE; BIRTH; ENCEPHALOCELE; FEMALE; FETUS; HEALTH CARE POLICY; HUMAN; MAJOR CLINICAL STUDY; MALE; MATERNAL CARE; MENINGOMYELOCELE; NEURAL TUBE DEFECT; NEWBORN; PATIENT COMPLIANCE; PEDIATRIC WARD; PREGNANCY OUTCOME; PREVALENCE; PROSPECTIVE STUDY; QUESTIONNAIRE; RISK FACTOR; SUPPLEMENTATION; SWITZERLAND; TREATMENT INDICATION;

EID: 54349088326     PISSN: 14247860     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Mulinare J, Erickson JD. Prevention of neural tube defects. Teratology. 1997;56:17-8.
2. Busby A, Abramsky L, Dolk H, Armstrong B. Preventing neural tube defects in Europe: population based study. BMJ. 2005;330:574-5.
3. Mitchell LE, Adzick NS, Melchionne J, Pasquariello PS, Sutton LN, Whitehead AS. Spina bifida. Lancet. 2004;364:1885-95.
4. Melnick M, Myrianthopoulos NC. Studies in neural tube defects. II. Pathologic findings in a prospectively collected series of anencephalics. Am J Med Genet. 1987;26:797-810.
5. Padmanabhan R. Etiology, pathogenesis and prevention of neural tube defects. Congenital anomalies. 2006;46:55-67.
6. Rowland CA, Correa A, Cragan JD, Alverson CJ. Are encephaloceles neural tube defects? Pediatrics. 2006;118:916-23.
7. Eichholzer M, Tonz O, Zimmermann R. Folic acid: a public-health challenge. Lancet. 2006;367:1352-61.
8. Baerlocher K, Eichholzer M, Lüthy J, Moser U, Tönz O. Folsäure: Expertenbericht der Eidgenössischen Ernä hrungskommission zur Prophylaxe von Neuralrohrdefekten. Edited by the Federal Office of Public Health; 2002.
9. Tonz O. Kommentar zur Erfassung der Neuralrohrdefekte. Paediatrica. 2002;13:84-5.
10. Rothenberg SP, da Costa MP, Sequeira JM, Cracco J, Roberts JL, Weedon J, et al. Autoantibodies against folate receptors in women with a pregnancy complicated by a neural-tube defect. N Engl J Med. 2004,350:134-42.
11. Lemire RJ. Neural tube defects. JAMA 1988;259:558-62.
12. Pacheco-Jacome E, Ballesteros MC, Jayakar P, Morrison G, Ragheb J, Medina LS. Occult spinal dysraphism: evidence-based diagnosis and treatment. Neuroimaging Clin N Am. 2003;13:327-34.
13. Yerby MS. Clinical care of pregnant women with epilepsy: neural tube defects and folic acid supplementation. Epilepsia. 2003;44(Suppl 3):33-40.
14. Botto LD, Lisi A, Robert-Gnansia E, Erickson JD, Vollset SE, Mastroiacovo P, et al. International retrospective cohort study of neural tube defects in relation to folic acid recommendations: are the recommendations working? BMJ. 2005;330:571.
15. Honein MA, Paulozzi LJ, Mathews TJ, Erickson JD, Wong LY. Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects. JAMA. 2001;285:2981-6.
16. Nikkila A, Rydhstrom H, Kallen B. The incidence of spina bifida in Sweden 1973-2003: the effect of prenatal diagnosis. Eur J Public Health. 2006;16:660-2.
17. Morris JK, Wald NJ. Prevalence of neural tube defect pregnancies in England and Wales from 1964 to 2004. J Med Screen. 2007;14:55-9.
18. Van Allen MI, Boyle E, Thiessen P, McFadden D, Cochrane D, Chambers GK et al. The impact of prenatal diagnosis on neural tube defect (NTD) pregnancy versus birth incidence in British Columbia. J Appl Genet. 2006;47:151-8.
19. Norem CT, Schoen EJ, Walton DL, Krieger RC, O'Keefe J, To TT et al. Routine ultrasonography compared with maternal serum alpha-fetoprotein for neural tube defect screening. Obstet Gynecol. 2005;106:747-52.
20. De Wals P, Tairou F, Van Allen MI, Uh SH, Lowry RB, Sibbald B et al. Reduction in neural-tube defects after folic acid fortification in Canada. N Engl J Med. 2007;357:135-42.
21. Persad VL, Van den Hof MC, Dube JM, Zimmer P. Incidence of open neural tube defects in Nova Scotia after folic acid fortification. CMAJ. 2002;167:241-5.
22. Lynch SA. Non-multifactorial neural tube defects. Am J Med Genet. 2005;135:69-76.
23. Steegers-Theunissen RP. Folate metabolism and neural tube defects: a review. Eur J Obstet Gynecol Reprod Biol. 1995;61:39-48.
24. O'Rahilly R, Muller F. The two sites of fusion of the neural folds and the two neuropores in the human embryo. Teratology. 2002;65:162-70.
25. Maddox DM, Manlapat A, Roon P, Prasad P, Ganapathy V, Smith SB. Reduced-folate carrier (RFC) is expressed in placenta and yolk sac, as well as in cells of the developing forebrain, hindbrain, neural tube, craniofacial region, eye, limb buds and heart. BMC Dev Biol. 2003;3:6.
26. Prasad PD, Ramamoorthy S, Moe AJ, Smith CH, Leibach FH, Ganapathy V. Selective expression of the high-affinity isoform of the folate receptor (FR-alpha) in the human placental syncytiotrophoblast and choriocarcinoma cells. Biochim Biophys Acta. 1994;1223:71-5.
27. De Marco P, Moroni A, Merello E, de Franchis R, Andreussi L, Finnell RH et al. Folate pathway gene alterations in patients with neural tube defects. Am J Med Genet. 2000;95:216-23.
28. Boyles AL, Hammock P, Speer MC. Candidate gene analysis in human neural tube defects. Am J Med Genet. 2005;135:9-23.
29. Finnell RH, Gould A, Spiegelstein O. Pathobiology and genetics of neural tube defects. Epilepsia. 2003;44(Suppl 3):14-23.
30. Czeizel AE, Dudas I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med. 1992;327:1832-5.
31. Berry RJ, Li Z, Erickson JD, Li S, Moore CA, Wang H et al. Prevention of neural-tube defects with folic acid in China. China-U.S. Collaborative Project for Neural Tube Defect Prevention. N Engl J Med. 1999;341:1485-90.
32. Lumley J, Watson L, Watson M, Bower C. Periconceptional supplementation with folate and/or multivitamins for preventing neural tube defects. Cochrane Database Syst Rev. 2001;3:CD001056.
33. Stoll C, Alembik Y, Dott B. Are the recommendations on the prevention of neural tube defects working? Eur J Med Genet. 2006;49:461-5.
34. Ray JG, Singh G, Burrows RF. Evidence for suboptimal use of periconceptional folic acid supplements globally. BJOG. 2004;111:399-408.
35. Knudsen VK, Orozova-Bekkevold I, Rasmussen LB, Mikkelsen TB, Michaelsen KF, Olsen SF. Low compliance with recommendations on folic acid use in relation to pregnancy: is there a need for fortification? Public Health Nutr. 2004;7:843-50.
36. Rader JI. Folic acid fortification, folate status and plasma homocysteine. J Nutr. 2002;132:2466S-70S.
37. Williams LJ, Mai CT, Edmonds LD, Shaw GM, Kirby RS, Hobbs CA, et al. Prevalence of spina bifida and anencephaly during the transition to mandatory folic acid fortification in the United States. Teratology. 2002;66:33-9.